TMH (Toyota Motor Corporation ADRhedged)
Insider Trading Activity
Every open-market purchase and sale reported by TMH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2017-01-30 | H. Lynn Massingale | Executive Chairman | A | — | — |
| 2016-09-21 | Leif M. Murphy | President and CEO | A | — | — |
| 2016-09-19 | Miles Snowden | Chief Medical Officer | MIXED | — | — |
| 2016-06-27 | H. Lynn Massingale | Executive Chairman | F | — | — |
| 2016-06-27 | David P. Jones | Executive VP and CFO | F | — | — |
| 2016-06-27 | Michael D Snow | President and CEO | F | — | — |
| 2016-06-23 | Miles Snowden | Chief Medical Officer | MIXED | — | — |
| 2016-06-23 | David P. Jones | Executive VP and CFO | MIXED | — | — |
| 2016-06-23 | Michael D Snow | President and CEO | MIXED | — | — |
| 2016-06-23 | Oliver Rogers | EVP and COO | M | — | — |
| 2016-06-23 | H. Lynn Massingale | Executive Chairman | MIXED | — | — |
| 2016-05-24 | Michael D Snow | President and CEO | MIXED | — | — |
| 2016-05-24 | Neil M Kurtz | Director | M | — | — |
| 2016-05-24 | Oliver Rogers | EVP and COO | M | — | — |
| 2016-05-24 | JOSEPH L HERRING | Director | M | — | — |
| 2016-05-24 | Glenn A. Davenport | Director | M | — | — |
| 2016-05-24 | Vicky B Gregg | Director | M | — | — |
| 2016-05-24 | JAMES L BIERMAN | Director | M | — | — |
| 2016-05-24 | H. Lynn Massingale | Executive Chairman | MIXED | — | — |
| 2016-05-24 | David P. Jones | Executive VP and CFO | MIXED | — | — |
| 2016-03-29 | JANA PARTNERS LLC | Director | A | — | — |
| 2016-03-29 | EDWIN M CRAWFORD | Director | A | — | — |
| 2016-03-29 | Scott Ostfeld | Director | A | — | — |
| 2016-03-14 | Steven E. Clifton | EVP and General Counsel | A | — | — |
| 2016-03-14 | Michael D Snow | President and CEO | A | — | — |
| 2016-03-14 | David P. Jones | Executive VP and CFO | A | — | — |
| 2016-03-14 | Oliver Rogers | EVP and COO | A | — | — |
| 2016-03-14 | H. Lynn Massingale | Executive Chairman | A | — | — |
| 2016-03-14 | Miles Snowden | Chief Medical Officer | A | — | — |
| 2016-03-10 | JOSEPH L HERRING | Director | A | — | — |
| 2016-03-10 | Glenn A. Davenport | Director | A | — | — |
| 2016-03-10 | Kenneth H Paulus | Director | A | — | — |
| 2016-03-10 | Neil M Kurtz | Director | A | — | — |
| 2016-03-10 | Mary R Grealy | Director | A | — | — |
| 2016-03-10 | Vicky B Gregg | Director | A | — | — |
| 2016-03-10 | JAMES L BIERMAN | Director | A | — | — |
| 2016-03-10 | Patrick Fry | Director | A | — | — |
| 2016-01-14 | H. Lynn Massingale | Executive Chairman | MIXED | — | — |
| 2015-08-14 | David P. Jones | Executive VP and CFO | MIXED | — | — |
| 2015-08-10 | Kenneth H Paulus | Director | Buy | — | — |
| 2015-07-13 | Kenneth H Paulus | Director | A | — | — |
| 2015-07-13 | Patrick Fry | Director | A | — | — |
| 2015-07-02 | H. Lynn Massingale | Executive Chairman | F | — | — |
| 2015-07-02 | Heidi S. Allen | SVP, General Counsel | F | — | — |
| 2015-07-02 | Michael D Snow | President and CEO | F | — | — |
| 2015-06-24 | H. Lynn Massingale | Executive Chairman | Sell | — | — |
| 2015-05-28 | H. Lynn Massingale | Executive Chairman | MIXED | — | — |
| 2015-05-26 | Miles Snowden | Chief Medical Officer | A | — | — |
| 2015-05-26 | Michael D Snow | President and CEO | A | — | — |
| 2015-05-26 | JAMES L BIERMAN | Director | A | — | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TMH quote page; the site-wide leaderboard is on the insider transactions hub.